Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

FingerMotion Inc. (FNGR) Releases Q1 2022 Reports Showing Continuing Upward Growth Trend

FingerMotion (FNGR) a rapidly evolving tech company serving markets in China, announced its financial results for the period Q1 2022 The company generated $6.00 million in revenue, representing the fourth consecutive quarter of record revenue The Telecommunications Products & Services (mobile recharge platform) and the SMS & MMS texting service sectors continued to show strong […]

Ideanomics Inc.’s (NASDAQ: IDEX) Sales To Finance to Charging (S2F2C) Business Model Paves Way For Exponential Growth Opportunities

Ideanomics’s EV market is expected to grow exponentially, driven by growing public awareness/acceptance and the U.S. administration’s support The company plans its expansion moves across three strong EV pillars: vehicles, charging, and energy IDEX acquisition of California-based Solectrac reflects the company’s approach to an electric tractor revolution In 2020, the number of global electric vehicles […]

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

Tryp Therapeutics is a drug developer whose mission is to find novel solutions to conditions with otherwise unmet needs The company has distinguished itself by developing a synthetic oral psilocybin product that it aims to use in the treatment of chronic pain and eating disorder indications under its psychedelic medicine research program Tryp’s management team […]

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX (NASDAQ: SRAX), a leading financial technology company that helps public companies unlock the power of data through its Sequire SaaS […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Pharmaceuticals also secures additional funding of $4.7 million for pivotal study and operations into Q2 […]

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has […]

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is making strategic moves as it progresses with pre-clinical and clinical trials. One of those steps includes […]

 

From Our Blog

Datavault AI Inc. (NASDAQ: DVLT) Drives Innovation as Global AI Expansion Accelerates

November 10, 2025

The astonishing rise of artificial intelligence (“AI”) is reinventing nearly every industry on the planet — and Datavault AI (NASDAQ: DVLT) is moving to claim its place among top AI operators. The company, which specializes in AI-driven data monetization, valuation and tokenization across multiple sectors, is positioning itself as a leader in the AI explosion by […]

Rotate your device 90° to view site.